Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis

CITEDBY Reports

  1. Z. Liu, L. Jiang, G. Liang, E. Song, W. Jiang, Y. Zheng, C. Gong, . Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management. Journal of Viral Hepatitis, 2017; (): .
    Crossref
  2. Sonali Paul, Asim Shuja, Idy Tam, Eun Min Kim, Sandra Kang, Leonid Kapulsky, Kathleen Viveiros, Hannah Lee, . Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy. Digestive Diseases and Sciences, 2016; 61(8): 2236.
    Crossref
  3. Nasrin Ahmadinejad, Sajjadeh Movahedinia, Samaneh Movahedinia, Kourosh Holakouie Naieni, Saharnaz Nejat, . Distribution of Breast Density in Iranian Women and its Association with Breast Cancer Risk Factors. Iranian Red Crescent Medical Journal, 2013; 15(12): .
    Crossref
  4. A. El Mekkaoui, Z. Benbrahim, O. El Mesbahi, A. Ibrahimi, N. Aqodad, . Traitement préemptif de la réactivation de l’hépatite virale B des patients sous chimiothérapie anticancéreuse. Journal Africain du Cancer / African Journal of Cancer, 2014; 6(1): 47.
    Crossref